Journal of Thoracic Oncology, ISSN 1556-0864, 10/2010, Volume 5, Issue 10, pp. S304 - S312
Thirty years have gone by since the Masaoka staging system of thymoma was proposed in 1981. Although the Masaoka staging system has been accepted by many...
Follow-up study | Staging system | Thymoma | TNM classification | SURVIVAL | METASTASIS | PROGNOSTIC-FACTORS | THYMIC EPITHELIAL TUMORS | ORGANIZATION HISTOLOGIC CLASSIFICATION | SURGICAL-TREATMENT | RESECTED THYMOMAS | ONCOLOGY | RESPIRATORY SYSTEM | RELEVANCE | RADIOTHERAPY | THYMECTOMY | Prognosis | Neoplasm Staging | Thymoma - pathology | Humans | Thymus Neoplasms - pathology
Follow-up study | Staging system | Thymoma | TNM classification | SURVIVAL | METASTASIS | PROGNOSTIC-FACTORS | THYMIC EPITHELIAL TUMORS | ORGANIZATION HISTOLOGIC CLASSIFICATION | SURGICAL-TREATMENT | RESECTED THYMOMAS | ONCOLOGY | RESPIRATORY SYSTEM | RELEVANCE | RADIOTHERAPY | THYMECTOMY | Prognosis | Neoplasm Staging | Thymoma - pathology | Humans | Thymus Neoplasms - pathology
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2005, Volume 23, Issue 15, pp. 3412 - 3420
Purpose There is a need for a simple, reliable staging system for multiple myeloma that can be applied internationally for patient classification and...
C-REACTIVE PROTEIN | SURVIVAL | SOUTHWEST-ONCOLOGY-GROUP | PROGNOSTIC-FACTORS | ONCOLOGY | ABNORMALITIES | HIGH-DOSE THERAPY | BETA-2-MICROGLOBULIN | PLASMA-CELL LEUKEMIA | EXPRESSION | I HEAVY-CHAIN | Multivariate Analysis | Predictive Value of Tests | Prognosis | Age Factors | Multiple Myeloma - mortality | Humans | Middle Aged | Male | Neoplasm Staging - standards | North America | Cause of Death | Multiple Myeloma - drug therapy | beta 2-Microglobulin - blood | Sensitivity and Specificity | Female | Retrospective Studies | Reproducibility of Results | Risk Assessment | Europe | Probability | Survival Rate | International Cooperation | Creatinine - urine | Serum Albumin - analysis | Multiple Myeloma - pathology | Platelet Count | Analysis of Variance | Asia | Sex Factors | Aged | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Cancer and Oncology | Medicin och hälsovetenskap | Cancer och onkologi
C-REACTIVE PROTEIN | SURVIVAL | SOUTHWEST-ONCOLOGY-GROUP | PROGNOSTIC-FACTORS | ONCOLOGY | ABNORMALITIES | HIGH-DOSE THERAPY | BETA-2-MICROGLOBULIN | PLASMA-CELL LEUKEMIA | EXPRESSION | I HEAVY-CHAIN | Multivariate Analysis | Predictive Value of Tests | Prognosis | Age Factors | Multiple Myeloma - mortality | Humans | Middle Aged | Male | Neoplasm Staging - standards | North America | Cause of Death | Multiple Myeloma - drug therapy | beta 2-Microglobulin - blood | Sensitivity and Specificity | Female | Retrospective Studies | Reproducibility of Results | Risk Assessment | Europe | Probability | Survival Rate | International Cooperation | Creatinine - urine | Serum Albumin - analysis | Multiple Myeloma - pathology | Platelet Count | Analysis of Variance | Asia | Sex Factors | Aged | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Cancer and Oncology | Medicin och hälsovetenskap | Cancer och onkologi
Journal Article
Annals of Internal Medicine, ISSN 0003-4819, 2012, Volume 156, Issue 10, pp. 684 - 695
Background: Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic lung disease with an overall poor prognosis. A simple-to-use staging system for IPF...
SURVIVAL | MEDICINE, GENERAL & INTERNAL | STANDARDIZATION | PROGNOSTIC MODELS | RISK | CLASSIFICATION | CLINICAL-COURSE | PREDICTION | Prognosis | Age Factors | Risk Assessment | Humans | Middle Aged | Male | Lung - physiopathology | Models, Statistical | Idiopathic Pulmonary Fibrosis - surgery | Vital Capacity | Lung Transplantation | Pulmonary Diffusing Capacity | Idiopathic Pulmonary Fibrosis - diagnosis | Idiopathic Pulmonary Fibrosis - mortality | Female | Idiopathic Pulmonary Fibrosis - physiopathology | Retrospective Studies | Pulmonary fibrosis | Research
SURVIVAL | MEDICINE, GENERAL & INTERNAL | STANDARDIZATION | PROGNOSTIC MODELS | RISK | CLASSIFICATION | CLINICAL-COURSE | PREDICTION | Prognosis | Age Factors | Risk Assessment | Humans | Middle Aged | Male | Lung - physiopathology | Models, Statistical | Idiopathic Pulmonary Fibrosis - surgery | Vital Capacity | Lung Transplantation | Pulmonary Diffusing Capacity | Idiopathic Pulmonary Fibrosis - diagnosis | Idiopathic Pulmonary Fibrosis - mortality | Female | Idiopathic Pulmonary Fibrosis - physiopathology | Retrospective Studies | Pulmonary fibrosis | Research
Journal Article
Cancer, ISSN 0008-543X, 03/2002, Volume 94, Issue 6, pp. 1760 - 1769
BACKGROUND. The current TNM staging system for patients with hepatocellular carcinoma (HCC) does not include liver function parameters and does not provide a...
Hepatocellular carcinoma | Staging system | Prognostic index | Survival | UNITED-STATES | ONCOLOGY | survival | prognostic index | CLINICAL-FEATURES | staging system | MULTIVARIATE-ANALYSIS | HONG-KONG | hepatocellular carcinoma | Prognosis | Prospective Studies | Humans | Middle Aged | Risk Factors | Male | Hepatitis B - complications | Neoplasm Staging - methods | Regression Analysis | Carcinoma, Hepatocellular - pathology | Aged, 80 and over | Adult | Female | Liver Neoplasms - pathology | Aged | Liver cancer | Identification and classification | Tumor staging | Methods | Tumors
Hepatocellular carcinoma | Staging system | Prognostic index | Survival | UNITED-STATES | ONCOLOGY | survival | prognostic index | CLINICAL-FEATURES | staging system | MULTIVARIATE-ANALYSIS | HONG-KONG | hepatocellular carcinoma | Prognosis | Prospective Studies | Humans | Middle Aged | Risk Factors | Male | Hepatitis B - complications | Neoplasm Staging - methods | Regression Analysis | Carcinoma, Hepatocellular - pathology | Aged, 80 and over | Adult | Female | Liver Neoplasms - pathology | Aged | Liver cancer | Identification and classification | Tumor staging | Methods | Tumors
Journal Article
Annals of Surgical Oncology, ISSN 1068-9265, 1/2009, Volume 16, Issue 1, pp. 14 - 22
The American Joint Committee on Cancer (AJCC)/International Union Against Cancer (UICC) staging system for liver cancer is based on data exclusively derived...
Oncology | Medicine & Public Health | Surgical Oncology | Surgery | MASS-FORMING TYPE | LIVER-CANCER | SURVIVAL | SURGERY | THAILAND | NUMBER | IMPACT | PROGNOSTIC-FACTORS | MODELS | ONCOLOGY | SURGICAL-TREATMENT | Bile Duct Neoplasms - surgery | Bile Ducts, Intrahepatic - pathology | SEER Program | Prognosis | Neoplasm Invasiveness | Humans | Male | Bile Duct Neoplasms - classification | Cholangiocarcinoma - pathology | Cholangiocarcinoma - surgery | Female | Aged | Bile Duct Neoplasms - pathology | Bile Ducts, Intrahepatic - surgery | Cholangiocarcinoma - classification | Neoplasm Staging | Liver cancer | Development and progression | Universities and colleges | Metastasis | Analysis
Oncology | Medicine & Public Health | Surgical Oncology | Surgery | MASS-FORMING TYPE | LIVER-CANCER | SURVIVAL | SURGERY | THAILAND | NUMBER | IMPACT | PROGNOSTIC-FACTORS | MODELS | ONCOLOGY | SURGICAL-TREATMENT | Bile Duct Neoplasms - surgery | Bile Ducts, Intrahepatic - pathology | SEER Program | Prognosis | Neoplasm Invasiveness | Humans | Male | Bile Duct Neoplasms - classification | Cholangiocarcinoma - pathology | Cholangiocarcinoma - surgery | Female | Aged | Bile Duct Neoplasms - pathology | Bile Ducts, Intrahepatic - surgery | Cholangiocarcinoma - classification | Neoplasm Staging | Liver cancer | Development and progression | Universities and colleges | Metastasis | Analysis
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 4, pp. 440 - 451
Summary Background Human papillomavirus-related (HPV+) oropharyngeal cancer is a rapidly emerging disease with generally good prognosis. Many prognostic...
Hematology, Oncology and Palliative Medicine | HEAD | P16 EXPRESSION | ONCOLOGY | SQUAMOUS-CELL CARCINOMA | DISTANT METASTASIS | RISK | CHEMORADIOTHERAPY | HUMAN-PAPILLOMAVIRUS | PROGNOSTIC-SIGNIFICANCE | RADIOTHERAPY | NECK-CANCER | Lymph Nodes - pathology | Prognosis | Humans | Middle Aged | Proportional Hazards Models | Male | Lymph Nodes - virology | Lymphatic Metastasis | Oropharyngeal Neoplasms - pathology | Oropharyngeal Neoplasms - virology | Papillomaviridae - isolation & purification | Viral Core Proteins - isolation & purification | Oropharyngeal Neoplasms - classification | Papillomaviridae - pathogenicity | Viral Core Proteins - biosynthesis | Female | Aged | Neoplasm Staging | Cohort Studies | Algorithms | Analysis | Oncology, Experimental | Research | Throat cancer | Papillomavirus infections | Cancer
Hematology, Oncology and Palliative Medicine | HEAD | P16 EXPRESSION | ONCOLOGY | SQUAMOUS-CELL CARCINOMA | DISTANT METASTASIS | RISK | CHEMORADIOTHERAPY | HUMAN-PAPILLOMAVIRUS | PROGNOSTIC-SIGNIFICANCE | RADIOTHERAPY | NECK-CANCER | Lymph Nodes - pathology | Prognosis | Humans | Middle Aged | Proportional Hazards Models | Male | Lymph Nodes - virology | Lymphatic Metastasis | Oropharyngeal Neoplasms - pathology | Oropharyngeal Neoplasms - virology | Papillomaviridae - isolation & purification | Viral Core Proteins - isolation & purification | Oropharyngeal Neoplasms - classification | Papillomaviridae - pathogenicity | Viral Core Proteins - biosynthesis | Female | Aged | Neoplasm Staging | Cohort Studies | Algorithms | Analysis | Oncology, Experimental | Research | Throat cancer | Papillomavirus infections | Cancer
Journal Article
Gastroenterology, ISSN 0016-5085, 2014, Volume 146, Issue 7, pp. 1691 - 1700.e3
Background & Aims We aimed to develop a prognostic classification scheme with treatment guidance for Asian patients with hepatocellular carcinoma (HCC)....
Gastroenterology and Hepatology | TACE | Prediction Model | Overall Survival | Outcome | PROSPECTIVE VALIDATION | MANAGEMENT | SCORE | STRATEGY | PREDICTING SURVIVAL | UNIVERSITY PROGNOSTIC INDEX | CLASSIFICATION | OKUDA | TRANSPLANTATION | GASTROENTEROLOGY & HEPATOLOGY | EPIDEMIOLOGY | Predictive Value of Tests | Carcinoma, Hepatocellular - mortality | Hong Kong | Area Under Curve | Humans | Middle Aged | Male | Liver Neoplasms - therapy | Liver Neoplasms - mortality | Patient Selection | Neoplasm Staging - methods | Young Adult | Time Factors | Aged, 80 and over | Adult | Female | Liver Neoplasms - pathology | Retrospective Studies | Carcinoma, Hepatocellular - ethnology | Risk Assessment | Risk Factors | Decision Support Techniques | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Chi-Square Distribution | Liver Neoplasms - ethnology | Asian Continental Ancestry Group | Adolescent | Carcinoma, Hepatocellular - pathology | ROC Curve | Aged | Carcinoma, Hepatocellular - therapy | Decision Trees | Liver cancer | Care and treatment | Hepatoma | Drug therapy | Cancer
Gastroenterology and Hepatology | TACE | Prediction Model | Overall Survival | Outcome | PROSPECTIVE VALIDATION | MANAGEMENT | SCORE | STRATEGY | PREDICTING SURVIVAL | UNIVERSITY PROGNOSTIC INDEX | CLASSIFICATION | OKUDA | TRANSPLANTATION | GASTROENTEROLOGY & HEPATOLOGY | EPIDEMIOLOGY | Predictive Value of Tests | Carcinoma, Hepatocellular - mortality | Hong Kong | Area Under Curve | Humans | Middle Aged | Male | Liver Neoplasms - therapy | Liver Neoplasms - mortality | Patient Selection | Neoplasm Staging - methods | Young Adult | Time Factors | Aged, 80 and over | Adult | Female | Liver Neoplasms - pathology | Retrospective Studies | Carcinoma, Hepatocellular - ethnology | Risk Assessment | Risk Factors | Decision Support Techniques | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Chi-Square Distribution | Liver Neoplasms - ethnology | Asian Continental Ancestry Group | Adolescent | Carcinoma, Hepatocellular - pathology | ROC Curve | Aged | Carcinoma, Hepatocellular - therapy | Decision Trees | Liver cancer | Care and treatment | Hepatoma | Drug therapy | Cancer
Journal Article
Annals of Surgery, ISSN 0003-4932, 03/2012, Volume 255, Issue 3, pp. 478 - 485
Objectives: The American Joint Committee on Cancer (AJCC) staging system for gastric cancer bases N status on absolute number of metastatic nodes, regardless...
UNITED-STATES | SURVIVAL | SURGERY | IMPACT | LYMPHADENECTOMY | ADENOCARCINOMA | GASTRECTOMY | CHEMORADIOTHERAPY | INDEPENDENT PROGNOSTIC-FACTOR | CARCINOMA | N-RATIO | Neoplasm Staging - methods | SEER Program | Lymph Nodes - pathology | Humans | Lymphatic Metastasis - pathology | Female | Male | Stomach Neoplasms - pathology | Aged
UNITED-STATES | SURVIVAL | SURGERY | IMPACT | LYMPHADENECTOMY | ADENOCARCINOMA | GASTRECTOMY | CHEMORADIOTHERAPY | INDEPENDENT PROGNOSTIC-FACTOR | CARCINOMA | N-RATIO | Neoplasm Staging - methods | SEER Program | Lymph Nodes - pathology | Humans | Lymphatic Metastasis - pathology | Female | Male | Stomach Neoplasms - pathology | Aged
Journal Article
Journal of Hepatology, ISSN 0168-8278, 2006, Volume 44, Issue 4, pp. 723 - 731
The Barcelona Clinic Liver Cancer (BCLC) classification offers a prognostic stratification of patients with hepatocellular carcinoma (HCC). We recently...
Tumor stage | Liver function | Hepatocellular carcinoma | Therapeutic decision | Prognosis | Staging | MANAGEMENT | JIS SCORE | CLASSIFICATION | prognosis | tumor stage | liver function | TRANSPLANTATION | therapeutic decision | HEPATOCELLULAR-CARCINOMA | PROGNOSTIC SYSTEM | CIRRHOTIC-PATIENTS | COHORT | RECURRENCE | CLIP SCORE | GASTROENTEROLOGY & HEPATOLOGY | staging | hepatocellular carcinoma | Multivariate Analysis | Predictive Value of Tests | Carcinoma, Hepatocellular - mortality | Prospective Studies | Humans | Middle Aged | Proportional Hazards Models | Male | Liver Neoplasms - therapy | Tumor Burden | Liver Neoplasms - mortality | Neoplasm Staging - methods | Time Factors | Lymphatic Metastasis - pathology | Carcinoma, Hepatocellular - pathology | Survival Analysis | Aged, 80 and over | Adult | Female | Liver Neoplasms - pathology | Aged | Carcinoma, Hepatocellular - therapy | Retrospective Studies | Liver cancer | Geology, Stratigraphic
Tumor stage | Liver function | Hepatocellular carcinoma | Therapeutic decision | Prognosis | Staging | MANAGEMENT | JIS SCORE | CLASSIFICATION | prognosis | tumor stage | liver function | TRANSPLANTATION | therapeutic decision | HEPATOCELLULAR-CARCINOMA | PROGNOSTIC SYSTEM | CIRRHOTIC-PATIENTS | COHORT | RECURRENCE | CLIP SCORE | GASTROENTEROLOGY & HEPATOLOGY | staging | hepatocellular carcinoma | Multivariate Analysis | Predictive Value of Tests | Carcinoma, Hepatocellular - mortality | Prospective Studies | Humans | Middle Aged | Proportional Hazards Models | Male | Liver Neoplasms - therapy | Tumor Burden | Liver Neoplasms - mortality | Neoplasm Staging - methods | Time Factors | Lymphatic Metastasis - pathology | Carcinoma, Hepatocellular - pathology | Survival Analysis | Aged, 80 and over | Adult | Female | Liver Neoplasms - pathology | Aged | Carcinoma, Hepatocellular - therapy | Retrospective Studies | Liver cancer | Geology, Stratigraphic
Journal Article
Pancreas, ISSN 0885-3177, 08/2010, Volume 39, Issue 6, pp. 707 - 712
Neuroendocrine tumors (NETs) arise in most organs of the body and share many common pathologic features. However, a variety of different organ-specific systems...
neuroendocrine tumor | pathology | stage | classification | NET | grade | SURVIVAL | CRITERIA | PROGNOSTIC-FACTORS | PANCREATIC ENDOCRINE NEOPLASMS | BEHAVIOR | PROTOCOL | PROPOSAL | SPECIMENS | CARCINOID-TUMORS | GASTROENTEROLOGY & HEPATOLOGY | EXPRESSION | Neuroendocrine Tumors - pathology | Terminology as Topic | Neuroendocrine Tumors - classification | Neoplasm Staging | Humans
neuroendocrine tumor | pathology | stage | classification | NET | grade | SURVIVAL | CRITERIA | PROGNOSTIC-FACTORS | PANCREATIC ENDOCRINE NEOPLASMS | BEHAVIOR | PROTOCOL | PROPOSAL | SPECIMENS | CARCINOID-TUMORS | GASTROENTEROLOGY & HEPATOLOGY | EXPRESSION | Neuroendocrine Tumors - pathology | Terminology as Topic | Neuroendocrine Tumors - classification | Neoplasm Staging | Humans
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 06/2016, Volume 34, Issue 16, pp. 1848 - 1854
Purpose Patients with human papillomavirus (HPV)-related oropharyngeal cancer (OPC) generally present with more advanced disease but have better survival than...
SURVIVAL | HEAD | P16 | ONCOLOGY | TONSILLAR CANCER | SQUAMOUS-CELL CARCINOMA | PROGNOSTIC-SIGNIFICANCE | NECK | EXPRESSION | CERVICAL INTRAEPITHELIAL NEOPLASIA | HUMAN-PAPILLOMAVIRUS ERA | Humans | Middle Aged | Oropharyngeal Neoplasms - mortality | Female | Male | Oropharyngeal Neoplasms - pathology | Oropharyngeal Neoplasms - virology | Retrospective Studies | Papillomaviridae - isolation & purification | Neoplasm Staging | ORIGINAL REPORTS | Hnc1 | Hnc2
SURVIVAL | HEAD | P16 | ONCOLOGY | TONSILLAR CANCER | SQUAMOUS-CELL CARCINOMA | PROGNOSTIC-SIGNIFICANCE | NECK | EXPRESSION | CERVICAL INTRAEPITHELIAL NEOPLASIA | HUMAN-PAPILLOMAVIRUS ERA | Humans | Middle Aged | Oropharyngeal Neoplasms - mortality | Female | Male | Oropharyngeal Neoplasms - pathology | Oropharyngeal Neoplasms - virology | Retrospective Studies | Papillomaviridae - isolation & purification | Neoplasm Staging | ORIGINAL REPORTS | Hnc1 | Hnc2
Journal Article
Journal of Gastroenterology, ISSN 0944-1174, 3/2003, Volume 38, Issue 3, pp. 207 - 215
A clinical staging system for cancer patients provides guidance for patient assessment and making therapeutic decisions. It is useful in deciding whether to...
prognostic staging system | CLIP score | BCLC classification | hepatocellular carcinoma | Japan integrated staging score (JIS score) | Hepatocellular carcinoma | Prognostic staging system | SURVIVAL | GROWTH-RATE | VALIDATION | CLASSIFICATION | NATURAL-HISTORY | HEPATIC RESECTION | FEATURES | TRANSCATHETER ARTERIAL EMBOLIZATION | CIRRHOSIS | MULTIVARIATE-ANALYSIS | GASTROENTEROLOGY & HEPATOLOGY | Neoplasm Staging - methods | Carcinoma, Hepatocellular - mortality | Liver Neoplasms - classification | Prognosis | Humans | Japan | Carcinoma, Hepatocellular - pathology | Liver Neoplasms - pathology | Survival Rate | Liver Neoplasms - mortality | Carcinoma, Hepatocellular - classification | Analysis | Cancer
prognostic staging system | CLIP score | BCLC classification | hepatocellular carcinoma | Japan integrated staging score (JIS score) | Hepatocellular carcinoma | Prognostic staging system | SURVIVAL | GROWTH-RATE | VALIDATION | CLASSIFICATION | NATURAL-HISTORY | HEPATIC RESECTION | FEATURES | TRANSCATHETER ARTERIAL EMBOLIZATION | CIRRHOSIS | MULTIVARIATE-ANALYSIS | GASTROENTEROLOGY & HEPATOLOGY | Neoplasm Staging - methods | Carcinoma, Hepatocellular - mortality | Liver Neoplasms - classification | Prognosis | Humans | Japan | Carcinoma, Hepatocellular - pathology | Liver Neoplasms - pathology | Survival Rate | Liver Neoplasms - mortality | Carcinoma, Hepatocellular - classification | Analysis | Cancer
Journal Article
Cancer, ISSN 0008-543X, 06/2010, Volume 116, Issue 12, pp. 3006 - 3014
BACKGROUND: Selecting an appropriate staging system is crucial to predict the outcome of patients with hepatocellular carcinoma (HCC). The optimal prognostic...
Tokyo score | Child‐Turcotte‐Pugh | tumor‐node‐metastasis | Barcelona Clinic Liver Cancer | cirrhosis | hepatocellular carcinoma | Japan Integrated Scoring | Cancer of the Liver Italian Program | SURVIVAL | MANAGEMENT | PROGNOSTIC-FACTORS | Child-Turcotte-Pugh | MODEL | LIVER-DISEASE | tumor-node-metastasis | THERAPY | ONCOLOGY | JAPAN | COHORT | CLIP SCORE
Tokyo score | Child‐Turcotte‐Pugh | tumor‐node‐metastasis | Barcelona Clinic Liver Cancer | cirrhosis | hepatocellular carcinoma | Japan Integrated Scoring | Cancer of the Liver Italian Program | SURVIVAL | MANAGEMENT | PROGNOSTIC-FACTORS | Child-Turcotte-Pugh | MODEL | LIVER-DISEASE | tumor-node-metastasis | THERAPY | ONCOLOGY | JAPAN | COHORT | CLIP SCORE
Journal Article
Clinical Obstetrics and Gynecology, ISSN 0009-9201, 06/2011, Volume 54, Issue 2, pp. 215 - 218
In 1988 the International Federation of Gynecologists and Obstetricians (FIGO) developed a surgical staging system for endometrial cancer. The FIGO staging...
FIGO | Endometrial cancer | staging | lymphadenectomy | RISK-FACTORS | PROGNOSTIC-FACTORS | endometrial cancer | PATTERNS | CARCINOMA | RADIATION | OBSTETRICS & GYNECOLOGY | Prognosis | Neoplasm Invasiveness | Humans | Endometrial Neoplasms - pathology | Female | Lymphatic Metastasis | Neoplasm Staging
FIGO | Endometrial cancer | staging | lymphadenectomy | RISK-FACTORS | PROGNOSTIC-FACTORS | endometrial cancer | PATTERNS | CARCINOMA | RADIATION | OBSTETRICS & GYNECOLOGY | Prognosis | Neoplasm Invasiveness | Humans | Endometrial Neoplasms - pathology | Female | Lymphatic Metastasis | Neoplasm Staging
Journal Article
Radiographics, ISSN 0271-5333, 10/2012, Volume 32, Issue 6, pp. 1805 - 1827
Cancers of the uterine corpus and cervix are the most common gynecologic malignancies worldwide. The International Federation of Gynecology and Obstetrics...
LYMPH-NODE METASTASES | DYNAMIC MR | ENDOMETRIAL CARCINOMA | PELVIC LYMPHADENECTOMY | INVASIVE CERVICAL-CANCER | APPARENT DIFFUSION-COEFFICIENT | MYOMETRIAL INVASION | PROGNOSTIC-SIGNIFICANCE | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | COMPUTED-TOMOGRAPHY | DIAGNOSTIC PERFORMANCE | Magnetic Resonance Imaging - methods | Female | Neoplasm Staging | Uterine Neoplasms - pathology | Humans | Sensitivity and Specificity
LYMPH-NODE METASTASES | DYNAMIC MR | ENDOMETRIAL CARCINOMA | PELVIC LYMPHADENECTOMY | INVASIVE CERVICAL-CANCER | APPARENT DIFFUSION-COEFFICIENT | MYOMETRIAL INVASION | PROGNOSTIC-SIGNIFICANCE | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | COMPUTED-TOMOGRAPHY | DIAGNOSTIC PERFORMANCE | Magnetic Resonance Imaging - methods | Female | Neoplasm Staging | Uterine Neoplasms - pathology | Humans | Sensitivity and Specificity
Journal Article